Cytochrome P450 Enzymes: |
---|
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0065007; biological regulation | GO:0006919; activation of cysteine-type endopeptidase activity involved in apoptotic process | 5.281E-07 | 3.068E-03 | CASP1, CASP7, LCK, XDH |
BP | GO:0008152; metabolic process | GO:0055114; oxidation-reduction process | 3.627E-06 | 5.794E-03 | ALDH1A1, ALOX15, CYP2D6, HPGD, HSD17B10, KDM4E, XDH |
BP | GO:0009987; cellular process | GO:0097194; execution phase of apoptosis | 3.865E-06 | 5.794E-03 | CASP1, CASP7, PRKCD |
BP | GO:0008152; metabolic process | GO:0038083; peptidyl-tyrosine autophosphorylation | 7.395E-06 | 7.668E-03 | EGFR, FYN, LCK |
BP | GO:0008152; metabolic process | GO:2001300; lipoxin metabolic process | 9.631E-06 | 8.388E-03 | ALOX15, HPGD |
BP | GO:0008152; metabolic process | GO:0032270; positive regulation of cellular protein metabolic process | 1.126E-05 | 8.754E-03 | ALOX15, CASP1, CASP7, EGFR, FYN, LCK, PRKCD, XDH |
MF | GO:0005488; binding | GO:0042610; CD8 receptor binding | 6.433E-07 | 3.068E-03 | FYN, LCK |
MF | GO:0003824; catalytic activity | GO:0004715; non-membrane spanning protein tyrosine kinase activity | 9.478E-06 | 8.388E-03 | FYN, LCK, PRKCD |
MF | GO:0005488; binding | GO:0042608; T cell receptor binding | 1.348E-05 | 9.417E-03 | FYN, LCK |
MF | GO:0005488; binding | GO:0042609; CD4 receptor binding | 1.348E-05 | 9.417E-03 | FYN, LCK |
Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|
hsa00232 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.994E-03 | 2.829E-02 | XDH |
hsa04066 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 3.007E-03 | 2.829E-02 | HIF1A; EGFR |
hsa04072 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 5.782E-03 | 3.277E-02 | FYN; EGFR |
hsa04380 | Osteoclast differentiation_Homo sapiens_hsa04380 | 4.883E-03 | 3.097E-02 | LCK; FYN |
hsa04520 | Adherens junction_Homo sapiens_hsa04520 | 1.567E-03 | 2.829E-02 | FYN; EGFR |
hsa04650 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 5.101E-03 | 3.097E-02 | LCK; FYN |
hsa04660 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.064E-03 | 2.829E-02 | LCK; FYN |
hsa04726 | Serotonergic synapse_Homo sapiens_hsa04726 | 3.543E-03 | 2.829E-02 | CYP2D6; ALOX15 |
hsa04912 | GnRH signaling pathway_Homo sapiens_hsa04912 | 2.357E-03 | 2.829E-02 | PRKCD; EGFR |
hsa04915 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 2.782E-03 | 2.829E-02 | PRKCD; EGFR |
ICD10 Disease Category | Disease Name | ICD10 Code | Linked Targets |
---|---|---|---|
A00-B99: Certain infectious and parasitic diseases | Malaria | B54 | CYP2D6 |
A00-B99: Certain infectious and parasitic diseases | Cryptosporidium infection | A07.2 | EGFR |
C00-D49: Neoplasms | Lung cancer | C33-C34 | EGFR |
C00-D49: Neoplasms | Lymphoma | C81-C86 | HIF1A; EGFR |
C00-D49: Neoplasms | Gastric cancer | C16 | EGFR; EGFR |
C00-D49: Neoplasms | Colorectal cancer | C18-C21 | EGFR; EGFR |
C00-D49: Neoplasms | Locally advanced head and neck cancer | C07-C14, C32, C33 | EGFR |
C00-D49: Neoplasms | Head and neck cancer | C07-C14, C32-C33 | EGFR; EGFR; EGFR |
C00-D49: Neoplasms | Head and neck squamous cell carcinoma | C44 | EGFR |
C00-D49: Neoplasms | Solid tumours | C00-D48 | HIF1A; EGFR |